Priority: 1
Related tags:
- Pharmacology in Anaesthesia
- System: Pharmacology in Anaesthesia
- Pharmacokinetic and pharmacodynamic principles
- Intravenous hypnotics and sedatives
- Inhalational anaesthetic pharmacology
- Opioids and non-opioid analgesics
- Neuromuscular blocking drugs and reversal
- Cardiovascular and autonomic pharmacology
- Perioperative adjuncts and drug safety
- Difficulty: Intermediate
- P1
- Exam: FCPS-II
- Difficulty: Advanced
- PK_HALF_LIFE_TIME_CONSTANT
- IV_BARBITURATES
- IV_ETOMIDATE
- INHAL_MAC_PHARMACODYNAMICS
- INHAL_AGENT_PROPERTIES_SELECTION
- OPIOID_CHRONIC_OUD
- NMB_SUXAMETHONIUM
- NMB_INTERACTIONS
- NMB_MONITORING_ONSET
- CV_VASOPRESSORS
- CV_INOTROPES
- PONV_PHARMACOLOGY
- COAGULATION_ANTIFIBRINOLYTICS
- Major: Pharmacokinetic and pharmacodynamic principles
- Major: Intravenous hypnotics and sedatives
- Major: Inhalational anaesthetic pharmacology
- Major: Opioids and non-opioid analgesics
- Major: Neuromuscular blocking drugs and reversal
- Major: Local anaesthetic pharmacology
- Major: Cardiovascular and autonomic pharmacology
- Major: Perioperative adjuncts and drug safety
- Exam-Tier: Primary
- Exam-Tier: Final
- Difficulty: Basic
- Local anaesthetic pharmacology
- Exam: Final FRCA
- Topic: Compartment models, distribution volumes and intercompartmental transfer
- Topic: Clearance, hepatic extraction, protein binding and organ dysfunction
- Topic: Elimination half-life, rate constants, time constants and accumulation
- Topic: Loading dose, maintenance dose, clearance and infusion calculations
- Topic: Redistribution, effect termination and context-sensitive decrement times
- Topic: Target-controlled infusion, plasma/effect-site targets and model limitations
- Topic: pKa, ionisation, lipid solubility, protein binding and membrane transfer
- Topic: Age, obesity, low cardiac output and altered dosing scalars
- Topic: Propofol pharmacology, haemodynamics, infusion and propofol infusion syndrome
- Topic: Thiopental and methohexital pharmacology, redistribution and complications
- Topic: Etomidate pharmacology, adrenal effects and clinical selection
- Topic: Ketamine pharmacology, analgesia, haemodynamics and neuropsychiatric effects
- Topic: Benzodiazepines, midazolam formulation, kinetics and flumazenil
- Topic: MAC, potency, age adjustment and physiological/pharmacological modifiers
- Topic: Uptake, cardiac output, ventilation and intracardiac/pulmonary shunts
- Topic: Comparative volatile-agent properties and patient-specific selection
- Topic: Biotransformation, organ toxicity, fluoride and compound-related effects
- Topic: Neuromuscular, cerebral, uterine and evoked-potential effects
- Topic: Comparative opioid kinetics, potency, onset, offset and procedural selection
- Topic: Opioid metabolism, active metabolites and dosing in renal/hepatic dysfunction
- Topic: Chronic opioid therapy, methadone, buprenorphine and opioid use disorder
- Topic: Pharmacogenetics, serotonergic toxicity and clinically important opioid interactions
- Topic: Neuraxial opioid pharmacology, spread, efficacy and delayed respiratory depression
- Topic: Opioid adverse effects, naloxone titration, tolerance and opioid-induced hyperalgesia
- Topic: Paracetamol, NSAIDs, ketamine, alpha-2 agonists and multimodal analgesia
- Topic: Suxamethonium pharmacology, phase blocks, hyperkalaemia and cholinesterase variants
- Topic: Aminosteroid and benzylisoquinolinium blockers: potency, kinetics and elimination
- Topic: Drug, electrolyte, temperature and disease interactions with neuromuscular block
- Topic: Onset, muscle-group differences and quantitative neuromuscular monitoring
- Topic: Neostigmine, antimuscarinic pairing, ceiling effect and residual block
- Topic: Sugammadex mechanism, dosing principles, limitations and adverse effects
- Topic: Neuromuscular-junction physiology, receptor behaviour, fade and block types
- Topic: Sodium-channel block, pKa, lipid solubility, protein binding and differential block
- Topic: Systemic absorption, injection-site vascularity, metabolism and maximum-dose reasoning
- Topic: CNS/cardiovascular toxicity, stereoselectivity and LAST recognition/management
- Topic: Ester/amide allergy, preservatives, antioxidants and formulation safety
- Topic: Adrenaline, bicarbonate and other local-anaesthetic adjuncts
- Topic: Norepinephrine, phenylephrine, vasopressin, metaraminol and ephedrine
- Topic: Epinephrine, dobutamine, phosphodiesterase inhibitors and calcium sensitisation
- Topic: Nitrates, sodium nitroprusside, hydralazine and pulmonary vasodilators
- Topic: Beta-blockers, alpha-blockers and perioperative adrenergic antagonism
- Topic: Atropine, glycopyrrolate, anticholinergic toxicity and cholinergic drugs
- Topic: Perioperative antiarrhythmics, electrophysiology and toxicity
- Topic: Risk-based antiemetic selection, mechanisms, combinations and adverse effects
- Topic: Enzyme inhibition/induction, transporter effects and perioperative drug interactions
- Topic: Perioperative anaphylaxis pharmacology and high-risk culprit recognition
- Topic: Tranexamic acid, protamine, heparin and selected haemostatic drugs
- Topic key: PK_COMPARTMENTS
- Topic key: PK_CLEARANCE_EXTRACTION
- Topic key: PK_HALF_LIFE_TIME_CONSTANT
- Topic key: PK_DOSING_INFUSION_CALC
- Topic key: PK_REDISTRIBUTION_CSHT
- Topic key: PK_TCI_EFFECT_SITE
- Topic key: PK_PHYSICOCHEM_IONISATION
- Topic key: PK_SPECIAL_POPULATIONS
- Topic key: IV_PROPOFOL
- Topic key: IV_BARBITURATES
- Topic key: IV_ETOMIDATE
- Topic key: IV_KETAMINE
- Topic key: IV_BENZODIAZEPINES
- Topic key: INHAL_MAC_PHARMACODYNAMICS
- Topic key: INHAL_UPTAKE_SHUNTS
- Topic key: INHAL_AGENT_PROPERTIES_SELECTION
- Topic key: INHAL_METABOLISM_TOXICITY
- Topic key: INHAL_CLINICAL_INTERACTIONS
- Topic key: OPIOID_PK_SELECTION
- Topic key: OPIOID_ORGAN_FAILURE
- Topic key: OPIOID_CHRONIC_OUD
- Topic key: OPIOID_INTERACTIONS_GENETICS
- Topic key: OPIOID_NEURAXIAL
- Topic key: OPIOID_ADVERSE_REVERSAL
- Topic key: NONOPIOID_ANALGESICS
- Topic key: NMB_SUXAMETHONIUM
- Topic key: NMB_NDMB_COMPARISON
- Topic key: NMB_INTERACTIONS
- Topic key: NMB_MONITORING_ONSET
- Topic key: NMB_ANTICHOLINESTERASE_REVERSAL
- Topic key: NMB_SUGAMMADEX
- Topic key: NMB_NMJ_PHYSIOLOGY
- Topic key: LA_PHYSICOCHEM_ACTION
- Topic key: LA_KINETICS_ABSORPTION
- Topic key: LA_TOXICITY_LAST
- Topic key: LA_ALLERGY_FORMULATION
- Topic key: LA_ADJUVANTS_ALKALINISATION
- Topic key: CV_VASOPRESSORS
- Topic key: CV_INOTROPES
- Topic key: CV_VASODILATORS
- Topic key: CV_ADRENERGIC_ANTAGONISTS
- Topic key: AUTONOMIC_ANTIMUSCARINICS
- Topic key: CV_ANTIARRHYTHMICS
- Topic key: PONV_PHARMACOLOGY
- Topic key: DRUG_INTERACTIONS_CYP
- Topic key: ALLERGY_ANAPHYLAXIS_DRUGS
- Topic key: COAGULATION_ANTIFIBRINOLYTICS
- Exam: Primary FRCA
- PK_COMPARTMENTS
- PK_CLEARANCE_EXTRACTION
- PK_DOSING_INFUSION_CALC
- PK_REDISTRIBUTION_CSHT
- PK_TCI_EFFECT_SITE
- PK_PHYSICOCHEM_IONISATION
- PK_SPECIAL_POPULATIONS
- IV_PROPOFOL
- IV_KETAMINE
- IV_BENZODIAZEPINES
- INHAL_UPTAKE_SHUNTS
- INHAL_METABOLISM_TOXICITY
- INHAL_CLINICAL_INTERACTIONS
- OPIOID_PK_SELECTION
- OPIOID_ORGAN_FAILURE
- OPIOID_INTERACTIONS_GENETICS
- OPIOID_NEURAXIAL
- OPIOID_ADVERSE_REVERSAL
- NONOPIOID_ANALGESICS
- NMB_NDMB_COMPARISON
- NMB_ANTICHOLINESTERASE_REVERSAL
- NMB_SUGAMMADEX
- NMB_NMJ_PHYSIOLOGY
- LA_PHYSICOCHEM_ACTION
- LA_KINETICS_ABSORPTION
- LA_TOXICITY_LAST
- LA_ALLERGY_FORMULATION
- LA_ADJUVANTS_ALKALINISATION
- CV_VASODILATORS
- CV_ADRENERGIC_ANTAGONISTS
- AUTONOMIC_ANTIMUSCARINICS
- CV_ANTIARRHYTHMICS
- DRUG_INTERACTIONS_CYP
- ALLERGY_ANAPHYLAXIS_DRUGS
- Exam: IMM
- Level: Basic
- Level: Advanced
- Level: Intermediate
- Exam: MCPS Anesthesia
- more...
- less...
No results for "Priority: 1"